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Introduction {#sec1-1}
============

Idiopathic rapid eye movement (REM) sleep behavior disorder (iRBD) is a parasomnia characterized by the loss of normal skeletal muscle atonia during REM sleep, with prominent motor activity that accompanies dream-enacting behaviors (Schenck and Mahowald, 2002). iRBD is thought to be a strong predictive factor for the development of neurodegenerative disorders, particularly those characterized by α-synuclein deposition (known as synucleinopathies), such as Parkinson's disease (PD), dementia with Lewy bodies, and multiple system atrophy (Gagnon et al., 2006; Boeve et al., 2007; Iranzo et al., 2013). Previous studies have attempted to identify biomarkers of neurodegeneration in iRBD patients to potentially predict to the development of synucleinopathies. For example, it has been reported that iRBD patients have regional changes in cerebral perfusion (Mazza et al., 2006; Vendette et al., 2011), brain glucose metabolic abnormalities (Wu et al., 2014; Ge et al., 2015), waking electroencephalographic impairments (Rodrigues Brazete et al., 2016), olfactory dysfunction (Fantini et al., 2006; Mahlknecht et al., 2015), and cognitive deficiencies (Fantini et al., 2011). Nevertheless, brain structural abnormalities have been poorly explored in iRBD patients.

Concerning the methodology, compared with hypothesis-driven region-of-interest analysis, hypothesis-free voxel-based morphometry (VBM) analysis is a fully automated, unbiased method and has been widely used to investigate neuropathological changes in neuropsychiatric illnesses and neurological disorders *in vivo* (Scherfler et al., 2011; Ford et al., 2013). Although recent studies have consistently demonstrated gray matter atrophy in iRBD patients (Ellmore et al., 2010; Hanyu et al., 2012; Rahayel et al., 2018), the distribution of gray matter loss was conflicting. Structural magnetic resonance imaging (MRI) investigations that were analyzed using VBM have highlighted gray matter structural alterations in unspecific and diverse regions, including the putamen, cerebellum, pons, parahippocampal gyrus, and frontal regions (Ellmore et al., 2010; Scherfler et al., 2011; Hanyu et al., 2012; Rahayel et al., 2018). Additionally, while previous studies have demonstrated region-specific perfusion or metabolic anomalies that are closely related to clinical markers in iRBD patients (Vendette et al., 2011; Ge et al., 2015), to the best of our knowledge, only one study has conducted a correlation analysis between gray matter volume (GMV) and clinical indices in this disorder (Rahayel et al., 2018). Furthermore, regional GMV in iRBD has not yet been investigated in a Chinese cohort.

This study thus aimed to investigate the GMV changes, and the relationships between GMV and clinical indices, in iRBD patients.

Participants and Methods {#sec1-2}
========================

Participants {#sec2-1}
------------

For this prospective cross-sectional study, 19 patients with iRBD (16 men and 3 women; mean age 66.6 ± 7.0 years) were enrolled consecutively at the Sleep and Wake Disorders Center of the Department of Neurology of Huashan Hospital, Fudan University, China. Average time between iRBD onset and MRI scanning time was 7.2 ± 4.2 years. All patients participating in this study fulfilled the clinical and polysomnographic (PSG) diagnosis criteria for iRBD, in accordance with the third edition of the International Classification of Sleep Disorders (Duchna, 2006; Montplaisir et al., 2010). All patients underwent a standard neurological examination and a Unified Parkinson's Disease Rating Scale motor exam (UPDRS III) (Ge et al., 2015), assessed by a blinded movement disorder specialist, and showed no overt signs of parkinsonism (UPDRS III score: 5.1 ± 4.8; range 0 to 19). None of the patients were treated with psychotropic medications. Patients showed no evidence of psychiatric disorders or dementia, and did not display any cognitive impairment according to the Mini-Mental State Examination score (28.8 ± 1.1; range 27 to 30) (Crum et al., 1993). Other exclusion criteria included drug-induced RBD, sleep apnea syndrome, electroencephalograph (EEG) abnormalities suggestive of epilepsy, central nervous system comorbidities such as brain tumor and encephalitis, unstable hypertension, and diabetes.

A total of 20 age-matched healthy individuals, including five men and 15 women (mean age 63.7 ± 5.9 years), were recruited based on the China-US Biomedical Collaborative Research Program (No. 81361120393). They had no history of neurological, sleep, or psychiatric disorders, and showed no or subtle white matter lesions on brain MRI scans. These subjects took the RBD Single-Question Screen instead of PSG to rule out the existence of RBD (Nomura et al., 2011; Chahine et al., 2013).

The protocol was approved by the Ethics Committee of Huashan Hospital (approval No. KY2013-336) on January 6, 2014 (**Additional file 1**). All subjects gave informed consent to participate after a detailed explanation of the procedures involved.

Polysomnographic evaluation {#sec2-2}
---------------------------

All iRBD patients underwent one night of audio-video-PSG monitoring (Philips Electronics, Amsterdam, the Netherlands) at our sleep center laboratory. Recordings of PSG are listed as follows: EEG with six-channel scalp EEG montages (F3/F4, C3/C4, O1/O2); bilateral electrooculography; electromyography (EMG) of mentalis and bilateral lower limbs. A nasal cannula and a mouth thermocouple were used to monitor respiration. Thoracoabdominal motion was detected by inductance plethysmogramy, and arterial oxyhemoglobin saturation (SpO~2~) was continuously recorded by a cutaneous finger pulse oximeter. Sleep stages 1--4 were recorded and manually scored according to standard criteria (Montplaisir et al., 2010). REM sleep was scored based on EEG and electrooculography recordings only. The REM sleep without atonia stage was defined by the presence of excessive phasic submental electromyographic (EMG) activity during REM sleep (\> 30% of REM sleep with tonic electromyographic EMG activity or \> 15% of REM sleep with phasic EMG activity) (Montplaisir et al., 2010). Audiovisual recordings were simultaneously conducted to monitor nocturnal sleep behaviors.

MRI scanning {#sec2-3}
------------

All MRI measurements were obtained on a 3-tesla GE Discovery MR750 Scanner (Milwaukee, WI, USA) equipped with a circular polarized 8-channel head matrix coil at the Department of Radiology of Huashan Hospital of Fudan University, China. High-resolution, T1-weighted, three-dimensional anatomical brain images were acquired using an inversion recovery prepared fast spoiled gradient recalled sequence (repetition time = 11.1 ms; echo time = 5.0 ms; flip angle = 20°; matrix resolution = 256 × 256; voxel size = 1 × 1 × 1 mm^3^; field of view = 240 mm^2^; slice thickness = 1.0 mm; 146 slices without slice gap, transverse acquisition), with the scan range from the calvarium to foramen magnum.

Data preprocessing {#sec2-4}
------------------

Image preprocessing was carried out using the VBM8 protocol (<http://dbm.neuro.uni-jena.de/vbm8/>) implemented within Matlab 8.3.0 (Mathworks, Inc, Sherborn, MA, USA) through Statistical Parametric Mapping version 8 (SPM8, [http//www.fil.ion.ucl.ac.uk/spm/software/spm8](http//www.fil.ion.ucl.ac.uk/spm/software/spm8)). The VBM method included several procedures. First, MRI scans from each subject were spatially normalized to the Montreal Neurological Institute/International Consortium for Brain Mapping 152 standard space template. In this step, voxel size was resampled to 3 × 3 × 3 mm^3^. Subsequently, the normalized MRI images were segmented into gray matter, white matter, and cerebrospinal fluid. Finally, the resulting gray matter images were smoothed with a 10 mm full width at half maximum Gaussian kernel to increase the signal-to-noise ratio for statistical analysis.

Statistical analysis {#sec2-5}
--------------------

SPM8 software ([http://www.fil.ion.ucl. ac.uk/spm/software/spm8/](http://www.fil.ion.ucl.ac.uk/spm/software/spm8/)) was used to analyze the MRI imaging data. A two-sample *t*-test was conducted to perform voxel-to-voxel comparisons of whole-brain GMV contrasts between the two groups. In the *t*-test, sex and total intracranial volume (gray matter + white matter + cerebrospinal fluid) were added as covariates. At voxel level, the significance threshold was set at *P* \< 0.01 uncorrected for multiple comparisons, with an extended cluster threshold of 160 voxels. The xjView 9.6 software (<http://www.alivelearn.net/xjview>) was used to display brain regions with significant differences (represented with pseudo color), activation volume (cluster size), activation intensity (statistically analyzed with a t-test and expressed as T value; the T value is proportional to the intensity), Montreal Neurological Institute coordinates, and Brodmann partition (Xia et al., 2013).

To investigate the relationship between regional GMV and clinical indices in iRBD patients, we also performed a multiple regression analysis. Separate correlation analyses were run on the iRBD data using the following clinical measurements: disease duration and EMG activity. Age and total intracranial volume were added as covariates into the model to correct for the interaction between these factors. Significance levels for correlation analyses were set at *P* \< 0.01 uncorrected for multiple comparisons, with an extended cluster threshold of 150 voxels. The xjView 9.6 software was used to display brain regions that correlated with clinical measurements (represented with pseudo color), activation volume (cluster size), activation intensity (statistically analyzed with multiple regression analysis and expressed as T value; the T value is proportional to the intensity), Montreal Neurological Institute coordinates, and Brodmann partition.

Statistical analyses of demographic and clinical variables were conducted using the IBM SPSS Statistics19 software package (IBM Corporation, Armonk, NY, USA). Parametric independent-sample *t*-tests were used to assess differences between groups in continuous variables with normal distribution. For the nonparametric data, chi-square tests were used to determine group differences. All analyses were considered statistically significant if *P* \< 0.05.

Results {#sec1-3}
=======

Demographic and clinical characteristics {#sec2-6}
----------------------------------------

**[Table 1](#T1){ref-type="table"}** presents the demographic, PSG, and clinical characteristics of the two groups. Groups were matched for age (*P* = 0.178). We found statistically significant differences between controls and iRBD patients in sex and total intracranial volume. Compared to controls, the percentage of men was significantly higher in iRBD patients (*P* = 0.000). In addition, the mean total intracranial volume was significantly lower in controls than in iRBD patients (*P* = 0.001). The study design is summarized in **[Figure 1](#F1){ref-type="fig"}**.

###### 

Demographic, polysomnographic, and clinical characteristics of participants

                                      iRBD patients    Controls        *P*-value
  ----------------------------------- ---------------- --------------- -------------
  Age (year)                          66.6 ± 7.0       63.7 ± 5.9      0.178^a^
  Sex (*n*, male/female)              16/3             5/15            \< 0.001^b^
  TIV (mL)                            1430.7 ± 102.4   1322.7 ± 88.5   0.001^a^
  UPDRS III (score)                   5.1± 4.8         NA              NA
  Disease duration (years)            7.2 ± 4.2        NA              NA
  Polysomnography variables                                            
   Total sleep duration (minute)      331.1 ± 43.7     NA              NA
   Sleep efficiency (%)               74.1 ± 10.0      NA              NA
   Stage 1 NREM (%)                   20.1 ± 7.2       NA              NA
   Stage 2 NREM (%)                   46.8 ± 7.6       NA              NA
   REM sleep time (minute)            59.4 ± 19.6      NA              NA
   Apnea-hypopnea index               9.9 ± 10.9       NA              NA
   Phasic EMG activity index/chin     20.6 ± 11.2      NA              NA
   Tonic EMG activity index/chin      21.6 ± 19.0      NA              NA
   Phasic EMG activity index/legs     14.2 ± 9.3       NA              NA
   Tonic EMG activity index/legs      8.8 ± 10.3       NA              NA
   Spontaneous microarousal index     20.2 ± 10.3      NA              NA
   Periodic limb movements in sleep   25.1 ± 33.5      NA              NA

^a^Independent-sample *t*-tests; ^b^Chi-square tests. iRBD: Idiopathic rapid eye movement sleep behavior disorder; TIV: total intracranial volume; UPDRS III: Unified Parkinson\'s Disease Rating Scale part III; REM: rapid eye movement; NREM: non-rapid eye movement; EMG: electromyograpic; NA: not available.

![Study flow chart.\
iRBD: Idiopathic rapid eye movement sleep behavior disorder; MRI: magnetic resonance imaging; PSG: polysomnographic; VBM: voxel-based morphometry.](NRR-14-868-g002){#F1}

VBM results {#sec2-7}
-----------

Relative to controls, iRBD patients exhibited reduced GMV in the right rolandic operculum, right postcentral gyrus, right insular lobe, right anterior cingulate gyrus, right precuneus, right posterior cingulate gyrus, left rectus gyrus, and bilateral superior frontal gyrus. Furthermore, iRBD patients displayed increased GMV in the right middle temporal gyrus and left cerebellar posterior lobe (**[Figure 2](#F2){ref-type="fig"}** and **[Table 2](#T2){ref-type="table"}**).

![Brain regions with relatively increased (red) and decreased (purple) gray matter volume in patients with idiopathic rapid eye movement sleep behavior disorder.\
Results of statistical analysis are superimposed onto the axial template brain mapping in the Montreal Neurological Institute standard coordinate system. Corresponding anatomical locations of color regions can be found in [Table 2](#T2){ref-type="table"}.](NRR-14-868-g003){#F2}

###### 

Brain regions with significant gray matter volume differences between iRBD patients and controls

  Regions                                                                  BA      Cluster size (voxels)   Peak intensity   Peak coordinates (mm)          
  ------------------------------------------------------------------------ ------- ----------------------- ---------------- ----------------------- ------ ------
  Increased gray matter volume                                                                                                                             
   Right middle temporal gyrus                                             21      301                     3.52             55                      --49   6
   Left cerebelum_4\_5; Left cerebelum_6                                   /       744                     3.28             --15                    --60   --28
  Decreased gray matter volume                                                                                                                             
   Right Rolandic operculum; Right postcentral gyrus; Right insular lobe   13,43   1286                    4.01             48                      --13   23
   Right anterior cingulate gyrus; Left superior frontal gyrus             9       544                     3.53             3                       44     21
   Right precuneus; Right posterior cingulate gyrus                        31      462                     3.18             7                       --51   23
   Left rectus gyrus; Left superior frontal gyrus                          11      415                     3.64             --3                     56     --25

iRBD: Idiopathic rapid eye movement sleep behavior disorder; BA: Brodmann area. Two-sample *t*-test, *P* \< 0.01 uncorrected for multiple comparisons.

Multiple regression analysis demonstrated that iRBD duration was positively correlated with GMV in the bilateral precuneus, bilateral calcarine fissure and surrounding cortex, bilateral cerebellar posterior lobe, right cuneus, right superior parietal gyrus, left postcentral gyrus, left posterior cingulate gyrus, left hippocampus, left lingual gyrus, left parahippocampal gyrus, left middle occipital gyrus, and left middle temporal gyrus. Furthermore, phasic chin EMG activity was positively correlated with GMV in the bilateral hippocampus, bilateral parahippocampal gyrus, bilateral precuneus, bilateral cerebellar posterior lobe, bilateral fusiform gyrus, right precentral gyrus, right superior frontal gyrus, right cuneus, right inferior parietal lobule, right angular gyrus, right superior parietal gyrus, right paracentral lobule, and left calcarine fissure and surrounding cortex (**Figures [3](#F3){ref-type="fig"}**, **[4](#F4){ref-type="fig"}** and **[Table 3](#T3){ref-type="table"}**).

![Brain regions correlate with the duration of idiopathic rapid eye movement sleep behavior disorder.\
Results of statistical analysis are superimposed on the axial template brain mapping in the Montreal Neurological Institute standard coordinate system. Corresponding anatomical locations of color regions can be found in [Table 3](#T3){ref-type="table"}.](NRR-14-868-g004){#F3}

![Brain regions correlate with phasic chin electromyographic activity in patients with idiopathic rapid eye movement sleep behavior disorder.\
Results of statistical analysis are superimposed on the axial template brain mapping in the Montreal Neurological Institute standard coordinate system. Corresponding anatomical locations of color regions can be found in [Table 3](#T3){ref-type="table"}.](NRR-14-868-g005){#F4}

###### 

Anatomical locations of regions with significant clinical correlation in iRBD patients

  Regions                                                                       BA      Cluster size (voxels)   Peak intensity   Peak coordinates (mm)          
  ----------------------------------------------------------------------------- ------- ----------------------- ---------------- ----------------------- ------ ------
  **Duration**                                                                                                                                                  
  *Positive*                                                                                                                                                    
   Bilateral precuneus; bilateral calcarine fissure and surrounding cortex      23,30   50148                   6.73             9                       --45   15
   Right cuneus                                                                 17                              4.99             15                      --96   14
   Left postcentral gyrus; bilateral precuneus; right superior parietal gyrus   5,7                             5.32             15                      --45   60
   Left posterior cingulate gyrus; left precuneus                               29                              5.24             --3                     --49   9
   Left posterior cingulate gyrus; left precuneus; left hippocampus             27,29                           6.22             --17                    --40   7
   Left hippocampus; left lingual gyrus; left parahippocampal gyrus             27,19                           6.24             --18                    --34   --6
   Left middle occipital gyrus                                                  19                              5.67             --33                    --70   33
   Left postcentral gyrus; bilateral precuneus                                  7,31                            5.28             8                       --72   33
   Right superior parietal gyrus; bilateral precuneus                           5,7                             5.27             15                      --67   57
   Left middle temporal gyrus                                                   21,22                           5.09             --68                    --33   1
   Left cerebellum_crus2                                                        /                               5.18             --39                    --66   --39
   Right cerebellum_crus1                                                       /                               5.65             30                      --79   --33
  **Phasic chin EMG activity**                                                                                                                                  
  *Positive*                                                                                                                                                    
   Right hippocampus; right fusiform gyrus; right parahippocampal gyrus         30,36   45897                   6.50             23                      --24   --15
   Right hippocampus; right parahippocampal gyrus                               28                              5.96             29                      --19   --11
   Left hippocampus; left fusiform gyrus; left parahippocampal gyrus            37                              6.06             --27                    --43   --12
   Right precentral gyrus; right superior frontal gyrus                         4,6                             6.29             44                      --16   60
   Right cuneus; bilateral precuneus                                            7                               5.79             8                       --72   33
   Right inferior parietal lobule; right angular gyrus                          39,40                           5.54             41                      --63   45
   Right precentral gyrus                                                       6                               5.60             44                      17     46
   Right superior parietal gyrus                                                7                               5.33             17                      --63   57
   Bilateral precuneus; right paracentral lobule                                5                               5.59             15                      --45   60
   Bilateral precuneus; left calcarine fissure and surrounding cortex           31,30                           5.26             0                       --66   19
   Right cerebellum_crus1                                                       /                               5.32             29                      --79   --32
   Left cerebellum_crus2                                                        /                               5.74             --39                    --63   --41

iRBD: Idiopathic rapid eye movement sleep behavior disorder; BA: Brodmann area; EMG: electromyographic. Multiple regression analysis, *P* \< 0.01 uncorrected for multiple comparisons.

Discussion {#sec1-4}
==========

In this article, we used VBM to investigate structural differences between the brains of healthy controls and iRBD patients. Additionally, using SPM analysis we also identified several brain regions that were volumetrically correlated with clinical measurements in iRBD patients.

A limited number of structural MRI studies have reported contradictory results in patients with iRBD (Ellmore et al., 2010; Scherfler et al., 2011; Hanyu et al., 2012; Rahayel et al., 2015), and gray matter changes are not entirely understood in this disorder. To further clarify the neuropathology from an anatomical viewpoint, we used VBM analysis to identify any regions with GMV changes in iRBD. The distribution of GMV reduction in the frontal and cingulate gyri in our iRBD population coincided with the atrophic regions previously described by Rahayel et al. (2015, 2018). Indeed, hypoperfusion and hypometabolism in the two regions has also been observed in iRBD patients using single photon emission computed tomography (Vendette et al., 2011, 2012) and positron emission tomography (Fujishiro et al., 2010; Ota et al., 2016). In addition, a study that performed quantitative analyses of waking EEG activity demonstrated considerably slower activity in the frontal regions of iRBD patients' brains (Rodrigues Brazete et al., 2016). Nevertheless, with uncertainty remaining, further research is needed to identify the exact relationships between structural and functional alterations in iRBD patients.

In contrast to earlier volumetric studies of iRBD, we detected no significant GMV reduction in the cerebellum, pons, parahippocampal gyrus (Hanyu et al., 2012), or putamen (Ellmore et al., 2010), nor a GMV increase in the hippocampus (Scherfler et al., 2011) of iRBD patients. These disparities might reflect methodological differences, which include sample size and patient characteristics, as well as image analysis approaches.

Of note, ours was a novel finding that iRBD patients had reduced GMV in the insular lobe, cingulate gyrus, postcentral gyrus, and rectus gyrus. Previously, despite lacking significance, a subtle GMV reduction in the insular lobe was observed in PD patients with probable RBD compared to those without probable RBD (Ford et al., 2013). Similarly, studies reported that PD patients with probable RBD exhibited diminished GMV in the cingulate gyrus (Boucetta et al., 2016; Lim et al., 2016). It could be speculated that the cingulate gyrus and insular lobe are strongly associated with RBD per se, irrespective of its existence as an idiopathic disease or a secondary disease associated with synucleinopathies. Similar to the results from iRBD patients in our study, a previous study found that patients with prodromal dementia with Lewy bodies had diminished GMV in the insular lobe and cingulate cortex (Blanc et al., 2016), which may suggest a potential connection between iRBD and dementia with Lewy bodies.

According to the widely acknowledged neuropathological staging proposed by Braak et al. (2003), the neurodegeneration responsible for RBD symptoms occurs early on, in the brain stem. The neurodegeneration then extends to the midbrain, where it gives rise to the motor symptoms of PD, before spreading to limbic and neocortical areas. However, our study demonstrated that the occurrence of structural neocortical involvement precedes mesencephalic region abnormalities, at least in iRBD. There are several possible interpretations for these discrepancies. First, in PD patients only slight midbrain atrophy has been detected, and there is no correlation between midbrain atrophy and striatal dopamine function (Makinen et al., 2016). As a potential precursor of PD, iRBD is thus believed to present mild midbrain atrophy or even no atrophy. Second, from a clinicopathological perspective, tau burden is closely associated with midbrain atrophy. In particular, the density of tau-positive structures, such as neurofibrillary tangles and glial fibrillary tangles, is reported to be strongly linked to the severity of midbrain atrophy (Aiba et al., 1997). As previously mentioned, iRBD appears to be a precursor for synucleinopathies, and this may account for the absence of atrophy in the midbrain in iRBD. Third, such a phenomenon would also be supported by the observation that cortical Alzheimer-type and α-synuclein pathological aggregation concurrently occur in a significant proportion of PD and dementia with Lewy bodies cases (Hurtig et al., 2000; Harding and Halliday, 2001; Pletnikova et al., 2005; Jellinger, 2012). It is tempting to suggest that this provides additional evidence that iRBD might have an analogous pathological feature. Nonetheless, pathophysiological substrates related to the GMV modifications observed in our iRBD patients need to be further investigated.

Besides GMV alterations in iRBD patients, we also detected correlations between structural changes and clinical measurements. It is of note that the regression analysis yielded exclusively positive correlations, either for iRBD duration or for phasic chin EMG activity, although this relationship is still unclear. However, we observed that mean total intracranial volume in our iRBD patients was significantly higher than in controls, and that similar neurofunctional correlations have been previously reported in iRBD populations. Whether drug therapy affects GMV and contributes to this finding in iRBD patients is unknown, and needs further investigation. The positive correlation between iRBD duration and GMV in the posterior cingulate gyrus is supported by previous research that demonstrated corresponding correlations of regional metabolism and perfusion with iRBD duration and deficient color vision discrimination, separately (Vendette et al., 2011; Ge et al., 2015). Likewise, perfusion in the cerebellar posterior lobe has been reported to positively correlate with a deficit in olfaction and color vision in iRBD patients (Vendette et al., 2011), which our findings also supported. Further studies applying multimodal neuroimaging techniques should be conducted to explore the interaction between metabolism/perfusion and anatomy.

Although previous studies have demonstrated increased perfusion, metabolism, or gray matter density in the hippocampus and parahippocampal gyrus (Scherfler et al., 2011; Vendette et al., 2011; Ge et al., 2015), prompting the neuronal reorganization of the hippocampal region in iRBD, no significant GMV modifications in this area were found in the current study. One potential reason for the absence of a GMV increase in this region might be the relatively short iRBD duration of our patients. However, we did observe that phasic chin EMG activity positively correlated with GMV in the hippocampal region. There are two possible interpretations for this result. First, earlier studies observed positive correlations between perfusion/metabolism in the hippocampus/parahippocampal gyrus, and phasic chin EMG activity, motor signs, olfactory disturbances, and color discrimination deficiencies in iRBD patients (Vendette et al., 2011; Dang-Vu et al., 2012; Ge et al., 2015). The positive correlation observed in the present study might then reinforce the concept that the hippocampus/parahippocampal gyrus is a critical component in the neuropathology of iRBD. Collectively, discoveries in the hippocampal regions validate the involvement of the limbic system, and support the idea of iRBD as a contributing factor for cognitive impairment, although this remains to be further investigated. In addition, the severity of REM atonia loss at baseline can predict imminent parkinsonism in iRBD patients (Postuma et al., 2010), and elevated hippocampal perfusion at baseline has been proposed to signal the neurodegeneration that converts RBD into synucleinopathies (Dang-Vu et al., 2012). Coupled with our findings, we speculate that GMV modifications in the hippocampal region may thus be a promising predictive imaging biomarker of impending conversion from iRBD. However, the precision of this prediction must be viewed with caution given our relatively limited sample size, and needs to be verified by a longer period of follow up in a larger iRBD cohort.

Despite adding possible confounding factors into the multiple regression design, such as age and total intracranial volume, we identified that brain regions correlating with the two clinical indices overlapped, such as in the bilateral cerebellar posterior lobe. One possible explanation might be that excessive tonic and phasic EMG activity during REM sleep increases over time in iRBD patients (Iranzo et al., 2009). Our generated overlapping area could therefore be a consequence of the synchronization of underpinning neuropathophysiological substrates of the two clinical indices.

There are some limitations in this study. First, the male to female ratio was discordant between the two groups. Considering that there are subtle differences in brain structures in healthy men and women (Cosgrove et al., 2007), we cannot rule out the possibility that this might have affected our results. Second, control subjects were enrolled simply based on a questionnaire and without validation of the diagnosis with PSG. Third, although VBM has been extensively used to detect gray matter loss, it has been proposed that VBM has inherent drawbacks (Davatzikos, 2004; Ioannidis, 2011), such as a tendency to significantly bias results towards group differences that are highly localized in space and linear nature. Finally, we had a relatively small sample size and the subjects were recruited from a single organization, which means that the participants were not a typical sample of the Chinese population. Thus, large-scale, multi-center research should be conducted using validated PSG-tested subjects, ideally in a prospective way.

In summary, we described brain GMV changes in iRBD patients using VBM. We also presented correlations between regional GMV and iRBD duration and phasic chin EMG activity, which primarily highlighted a limbic involvement. Our findings provide anatomical bases for previously observed disturbances in cerebral function and clinical manifestations in this population. Future longitudinal studies in our iRBD cohort are needed to clarify the eventual outcomes of our iRBD patients, and to elucidate whether specific gray matter abnormalities could predict progression towards synucleinopathies.
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